Novo-Nordisk
NVO
Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them
Managers holding
3
In their latest 13F (Q3 2026)
See who
Value held
$1.1bn
Combined value at quarter end
Last quarter
1 bought
1 sold or trimmed
Fund portfolios
2
Funds holding it
See which
Price at Q2 ’26 end
$47.94
+30.4% in the quarter
Share price change by quarter
-16.6%Q3 ’24
-27.8%Q4 ’24
-19.3%Q1 ’25
-0.6%Q2 ’25
-19.6%Q3 ’25
-8.3%Q4 ’25
-27.8%Q1 ’26
+30.4%Q2 ’26
Managers holding it, by quarter
4Q4 ’23
4Q1 ’24
4Q2 ’24
4Q3 ’24
4Q4 ’24
4Q1 ’25
4Q2 ’25
3Q3 ’25
3Q4 ’25
4Q1 ’26
3Q2 ’26
0Q3 ’26
Who holds it
| Markel Group | 1.1%$138m | Unchanged |
| Dodge & Cox | 0.5%$978m | Added +5.5% |
| Horizon Kinetics | 0.0%$736k | Unchanged |
About the company
- Sector
- Health care · Pharmaceutical Preparations
- Financial year ends
- 31 December
- SEC filings
- Annual reports and other filings on EDGAR
Sold out last quarter
- Giverny Capital in Q2 2026
In fund portfolios
| Dodge & Cox International Stock FundDodge & Cox | 0.9% |
| Dodge & Cox Global Stock FundDodge & Cox | 0.6% |